Mroczek-Musulman E - Search Results

1

CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells.

Marayati R, Stafman LL, Williams AP, Bownes LV, Quinn CH, Markert HR, Easlick JL, Stewart JE, Crossman DK, Mroczek-Musulman E, Beierle EA. Marayati R, et al. Among authors: mroczek musulman e. Cancer Gene Ther. 2022 May;29(5):558-572. doi: 10.1038/s41417-021-00334-4. Epub 2021 Apr 16. Cancer Gene Ther. 2022. PMID: 33864024 Free PMC article.

2

FAK Inhibition Decreases Hepatoblastoma Survival Both In Vitro and In Vivo.

Gillory LA, Stewart JE, Megison ML, Nabers HC, Mroczek-Musulman E, Beierle EA. Gillory LA, et al. Transl Oncol. 2013 Apr;6(2):206-15. doi: 10.1593/tlo.12505. Epub 2013 Apr 1. Transl Oncol. 2013. PMID: 23544173 Free PMC article.

3

Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of neuroblastoma.

Gillory LA, Megison ML, Stewart JE, Mroczek-Musulman E, Nabers HC, Waters AM, Kelly V, Coleman JM, Markert JM, Gillespie GY, Friedman GK, Beierle EA. Gillory LA, et al. PLoS One. 2013 Oct 10;8(10):e77753. doi: 10.1371/journal.pone.0077753. eCollection 2013. PLoS One. 2013. PMID: 24130898 Free PMC article.

4

Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of pediatric solid tumors.

Megison ML, Gillory LA, Stewart JE, Nabers HC, Mroczek-Musulman E, Waters AM, Coleman JM, Kelly V, Markert JM, Gillespie GY, Friedman GK, Beierle EA. Megison ML, et al. PLoS One. 2014 Jan 30;9(1):e86843. doi: 10.1371/journal.pone.0086843. eCollection 2014. PLoS One. 2014. PMID: 24497984 Free PMC article.

5

Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma.

Waters AM, Stewart JE, Atigadda VR, Mroczek-Musulman E, Muccio DD, Grubbs CJ, Beierle EA. Waters AM, et al. Mol Cancer Ther. 2015 Jul;14(7):1559-69. doi: 10.1158/1535-7163.MCT-14-1103. Epub 2015 May 5. Mol Cancer Ther. 2015. PMID: 25944918 Free PMC article.

6

Preclinical Evaluation of UAB30 in Pediatric Renal and Hepatic Malignancies.

Waters AM, Stewart JE, Atigadda VR, Mroczek-Musulman E, Muccio DD, Grubbs CJ, Beierle EA. Waters AM, et al. Mol Cancer Ther. 2016 May;15(5):911-21. doi: 10.1158/1535-7163.MCT-15-0521. Epub 2016 Feb 12. Mol Cancer Ther. 2016. PMID: 26873726 Free PMC article.

7

Targeting Focal Adhesion Kinase Suppresses the Malignant Phenotype in Rhabdomyosarcoma Cells.

Waters AM, Stafman LL, Garner EF, Mruthyunjayappa S, Stewart JE, Mroczek-Musulman E, Beierle EA. Waters AM, et al. Transl Oncol. 2016 Aug;9(4):263-73. doi: 10.1016/j.tranon.2016.06.001. Epub 2016 Jun 24. Transl Oncol. 2016. PMID: 27567948 Free PMC article.

8

FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts.

Garner EF, Williams AP, Stafman LL, Aye JM, Mroczek-Musulman E, Moore BP, Stewart JE, Friedman GK, Beierle EA. Garner EF, et al. Sci Rep. 2018 May 2;8(1):6913. doi: 10.1038/s41598-018-25263-5. Sci Rep. 2018. PMID: 29720672 Free PMC article.

9

Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma.

Stafman LL, Mruthyunjayappa S, Waters AM, Garner EF, Aye JM, Stewart JE, Yoon KJ, Whelan K, Mroczek-Musulman E, Beierle EA. Stafman LL, et al. Oncotarget. 2018 Apr 27;9(32):22665-22679. doi: 10.18632/oncotarget.25205. eCollection 2018 Apr 27. Oncotarget. 2018. PMID: 29854306 Free PMC article.

10

A novel retinoid X receptor agonist, UAB30, inhibits rhabdomyosarcoma cells in vitro.

Williams AP, Waters AM, Stewart JE, Atigadda VR, Mroczek-Musulman E, Muccio DD, Grubbs CJ, Beierle EA. Williams AP, et al. J Surg Res. 2018 Aug;228:54-62. doi: 10.1016/j.jss.2018.02.057. Epub 2018 Mar 26. J Surg Res. 2018. PMID: 29907230 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

43 results

Search Page